Levetiracetam Tecnigen

Levetiracetam, the active ingredient in Levetiracetam Tecnigen, is an anticonvulsant presented as an oral tablet for oral use. It is used to control partial‑onset, generalized tonic‑clonic and myoclonic seizures in patients with epilepsy across the European market. Levetiracetam Tecnigen is a generic formulation that follows EU quality standards and is indicated for adjunctive therapy in seizure management.

GNH USA supplies Levetiracetam Tecnigen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic drug that modulates neuronal excitability to reduce seizure activity.

Partial‑onset seizures: reduces seizure frequency and helps achieve seizure control. Generalized tonic‑clonic seizures: decreases occurrence of convulsive episodes. Myoclonic seizures: lessens rapid muscle jerks associated with epilepsy.

Levetiracetam is generally well tolerated, but a range of adverse reactions have been reported.

Common Side Effects: - Drowsiness - Dizziness - Headache - Irritability - Nausea - Fatigue

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Skin rash or Stevens‑Johnson syndrome - Suicidal thoughts or behavior - Severe depression - Hepatic dysfunction

When prescribing levetiracetam, clinicians should consider several safety aspects.

Renal impairment: adjust dose as recommended by prescriber. Hepatic disease: monitor liver function regularly. Pregnancy: risk unknown, discuss potential benefits and risks with physician. Psychiatric symptoms: monitor for mood changes, depression, or suicidal ideation. Concomitant CNS depressants: may increase sedation. Store at ambient temperature below 25°C: keep in original packaging, protect from moisture.

Levetiracetam may interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels. - Phenytoin: may lower levetiracetam exposure. - Phenobarbital: may decrease levetiracetam efficacy.

Moderate Interactions (Monitor Closely): - Alcohol: can enhance central nervous system depression. - Other antiepileptics (e.g., valproate): monitor for additive effects. - CYP enzyme inducers (e.g., rifampin): may affect levetiracetam plasma concentrations.